 | • レポートコード：QY2108PAL8886 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける髄膜炎菌ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、髄膜炎菌ワクチンの種類別市場規模（髄膜炎A、多糖類髄膜炎AC、髄膜炎ACYW）、用途別市場規模（6ヶ月-15歳、3歳以上、2歳以上、3ヶ月以上）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の髄膜炎菌ワクチン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における髄膜炎菌ワクチンの種類別市場規模（2016年-2027年）：髄膜炎A、多糖類髄膜炎AC、髄膜炎ACYW ・世界における髄膜炎菌ワクチンの用途別市場規模（2016年-2027年）：6ヶ月-15歳、3歳以上、2歳以上、3ヶ月以上 ・髄膜炎菌ワクチンの中国市場分析 - 髄膜炎菌ワクチンの中国市場規模（2016年-2027年） - 中国における髄膜炎菌ワクチンの主要プレイヤー別市場シェア - 中国における髄膜炎菌ワクチンの種類別市場規模：髄膜炎A、多糖類髄膜炎AC、髄膜炎ACYW - 中国における髄膜炎菌ワクチンの用途別市場規模：6ヶ月-15歳、3歳以上、2歳以上、3ヶ月以上 ・髄膜炎菌ワクチンの北米市場（2016年-2027年） ・髄膜炎菌ワクチンのヨーロッパ市場（2016年-2027年） ・髄膜炎菌ワクチンのアジア太平洋市場（2016年-2027年） ・髄膜炎菌ワクチンの中南米市場（2016年-2027年） ・髄膜炎菌ワクチンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Novartis、GSK、Merck、CSL、Baxter、JN International Medical Corporation、Serum Institute of India、Bio-Med、China National Biotec Group、Hualan Bio、Walvax、Zhifei ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
Market Analysis and Insights: Global and China Meningococcal Vaccine Market
This report focuses on global and China Meningococcal Vaccine market.
In 2020, the global Meningococcal Vaccine market size was US$ 251 million and it is expected to reach US$ 339.2 million by the end of 2027, with a CAGR of 4.4% during 2021-2027. In China the Meningococcal Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Meningococcal Vaccine Scope and Market Size
Meningococcal Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Meningococcal Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
1 Study Coverage
1.1 Meningococcal Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type
1.2.2 Meningtits A
1.2.3 Polysaccharide Meningtitis AC
1.2.4 Meningitis ACYW
1.3 Market by Application
1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Meningococcal Vaccine Revenue 2016-2027
2.1.2 Global Meningococcal Vaccine Sales 2016-2027
2.2 Global Meningococcal Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Meningococcal Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Meningococcal Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Meningococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Meningococcal Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Meningococcal Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027)
3 Global Meningococcal Vaccine Competitor Landscape by Players
3.1 Global Top Meningococcal Vaccine Manufacturers by Sales
3.1.1 Global Meningococcal Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Meningococcal Vaccine Manufacturers by Revenue
3.2.1 Key Meningococcal Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Meningococcal Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Meningococcal Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2020
3.2.6 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Meningococcal Vaccine Price by Manufacturers
3.4 Global Meningococcal Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Meningococcal Vaccine Market Size by Type (2016-2021)
4.1.1 Global Meningococcal Vaccine Sales by Type (2016-2021)
4.1.2 Global Meningococcal Vaccine Revenue by Type (2016-2021)
4.1.3 Meningococcal Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Meningococcal Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Meningococcal Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Meningococcal Vaccine Market Size by Application (2016-2021)
5.1.1 Global Meningococcal Vaccine Sales by Application (2016-2021)
5.1.2 Global Meningococcal Vaccine Revenue by Application (2016-2021)
5.1.3 Meningococcal Vaccine Price by Application (2016-2021)
5.2 Meningococcal Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Meningococcal Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Meningococcal Vaccine Sales YoY Growth 2016-2027
6.1.2 China Meningococcal Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Meningococcal Vaccine Market Share in Global Market 2016-2027
6.2 China Meningococcal Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Meningococcal Vaccine Players by Sales (2016-2021)
6.2.2 China Top Meningococcal Vaccine Players by Revenue (2016-2021)
6.3 China Meningococcal Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Meningococcal Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Meningococcal Vaccine Price by Type (2016-2021)
6.4 China Meningococcal Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Meningococcal Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Meningococcal Vaccine Price Forecast by Type (2022-2027)
6.5 China Meningococcal Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Meningococcal Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Meningococcal Vaccine Price by Application (2016-2021)
6.6 China Meningococcal Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Meningococcal Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Meningococcal Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Meningococcal Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Meningococcal Vaccine Market Size YoY Growth 2016-2027
7.2 North America Meningococcal Vaccine Market Facts & Figures by Country
7.2.1 North America Meningococcal Vaccine Sales by Country (2016-2021)
7.2.2 North America Meningococcal Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Meningococcal Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Meningococcal Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Meningococcal Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Meningococcal Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Meningococcal Vaccine Market Facts & Figures by Country
9.2.1 Europe Meningococcal Vaccine Sales by Country (2016-2021)
9.2.2 Europe Meningococcal Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Meningococcal Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Meningococcal Vaccine Market Facts & Figures by Country
10.2.1 Latin America Meningococcal Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Meningococcal Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Meningococcal Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Meningococcal Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Meningococcal Vaccine Products Offered
12.1.5 Novartis Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Meningococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Meningococcal Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 CSL
12.4.1 CSL Corporation Information
12.4.2 CSL Description and Business Overview
12.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CSL Meningococcal Vaccine Products Offered
12.4.5 CSL Recent Development
12.5 Baxter
12.5.1 Baxter Corporation Information
12.5.2 Baxter Description and Business Overview
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Baxter Meningococcal Vaccine Products Offered
12.5.5 Baxter Recent Development
12.6 JN International Medical Corporation
12.6.1 JN International Medical Corporation Corporation Information
12.6.2 JN International Medical Corporation Description and Business Overview
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
12.6.5 JN International Medical Corporation Recent Development
12.7 Serum Institute of India
12.7.1 Serum Institute of India Corporation Information
12.7.2 Serum Institute of India Description and Business Overview
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
12.7.5 Serum Institute of India Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Corporation Information
12.8.2 Bio-Med Description and Business Overview
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bio-Med Meningococcal Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 China National Biotec Group
12.9.1 China National Biotec Group Corporation Information
12.9.2 China National Biotec Group Description and Business Overview
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
12.9.5 China National Biotec Group Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Corporation Information
12.10.2 Hualan Bio Description and Business Overview
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hualan Bio Meningococcal Vaccine Products Offered
12.10.5 Hualan Bio Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Meningococcal Vaccine Products Offered
12.11.5 Novartis Recent Development
12.12 Zhifei
12.12.1 Zhifei Corporation Information
12.12.2 Zhifei Description and Business Overview
12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhifei Products Offered
12.12.5 Zhifei Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Meningococcal Vaccine Industry Trends
13.2 Meningococcal Vaccine Market Drivers
13.3 Meningococcal Vaccine Market Challenges
13.4 Meningococcal Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Meningtits A
Table 3. Major Manufacturers of Polysaccharide Meningtitis AC
Table 4. Major Manufacturers of Meningitis ACYW
Table 5. Global Meningococcal Vaccine Market Size Growth Rate by Application (2021-2027) & (10K Pcs)
Table 6. Global Meningococcal Vaccine Market Size by Region (10K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Meningococcal Vaccine Sales by Regions (2016-2021) & (10K Pcs)
Table 8. Global Meningococcal Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Meningococcal Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Vaccine Sales Forecast by Region (2022-2027) & (10K Pcs)
Table 11. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Meningococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Meningococcal Vaccine Sales by Manufacturers (2016-2021) (10K Pcs)
Table 15. Global Meningococcal Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Meningococcal Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Meningococcal Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Meningococcal Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2020)
Table 21. Key Manufacturers Meningococcal Vaccine Price (2016-2021) (USD/Pcs)
Table 22. Meningococcal Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Meningococcal Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Meningococcal Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Vaccine Sales by Type (2016-2021) (10K Pcs)
Table 27. Global Meningococcal Vaccine Sales Share by Type (2016-2021)
Table 28. Global Meningococcal Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Meningococcal Vaccine Revenue Share by Type (2016-2021)
Table 30. Meningococcal Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 31. Global Meningococcal Vaccine Sales Forecast by Type (2022-2027) & (10K Pcs)
Table 32. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Meningococcal Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Meningococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Meningococcal Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 36. Global Meningococcal Vaccine Sales by Application (2016-2021) (10K Pcs)
Table 37. Global Meningococcal Vaccine Sales Share by Application (2016-2021)
Table 38. Global Meningococcal Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Meningococcal Vaccine Revenue Share by Application (2016-2021)
Table 40. Meningococcal Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 41. Global Meningococcal Vaccine Sales Forecast by Application (2022-2027) & (10K Pcs)
Table 42. Global Meningococcal Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Meningococcal Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Meningococcal Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 46. China Meningococcal Vaccine Sales (10K Pcs) of Key Companies (2016-2021)
Table 47. China Meningococcal Vaccine Sales Share by Company (2016-2021)
Table 48. China Meningococcal Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Meningococcal Vaccine Revenue Share by Company (2016-2021)
Table 50. China Meningococcal Vaccine Sales (10K Pcs) by Type (2016-2021)
Table 51. China Meningococcal Vaccine Sales Share by Type (2016-2021)
Table 52. China Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Meningococcal Vaccine Price (USD/Pcs) by Type (2016-2021)
Table 54. China Meningococcal Vaccine Sales (10K Pcs) by Type (2022-2027)
Table 55. China Meningococcal Vaccine Sales Share by Type (2022-2027)
Table 56. China Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Meningococcal Vaccine Revenue Share by Type (2022-2027)
Table 58. China Meningococcal Vaccine Price (USD/Pcs) by Type (2022-2027)
Table 59. China Meningococcal Vaccine Sales (10K Pcs) by Application (2016-2021)
Table 60. China Meningococcal Vaccine Sales Share by Application (2016-2021)
Table 61. China Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Meningococcal Vaccine Price (USD/Pcs) by Application (2016-2021)
Table 63. China Meningococcal Vaccine Sales (10K Pcs) by Application (2022-2027)
Table 64. China Meningococcal Vaccine Sales Share by Application (2022-2027)
Table 65. China Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Meningococcal Vaccine Revenue Share by Application (2022-2027)
Table 67. China Meningococcal Vaccine Price (USD/Pcs) by Application (2022-2027)
Table 68. North America Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 69. North America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Meningococcal Vaccine Sales by Region (2016-2021) & (10K Pcs)
Table 73. Asia Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Meningococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 77. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 81. Latin America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Meningococcal Vaccine Sales by Country (2016-2021) & (10K Pcs)
Table 85. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Meningococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Novartis Meningococcal Vaccine Product
Table 92. Novartis Recent Development
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. GSK Product
Table 97. GSK Recent Development
Table 98. Merck Corporation Information
Table 99. Merck Description and Business Overview
Table 100. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Merck Product
Table 102. Merck Recent Development
Table 103. CSL Corporation Information
Table 104. CSL Description and Business Overview
Table 105. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. CSL Product
Table 107. CSL Recent Development
Table 108. Baxter Corporation Information
Table 109. Baxter Description and Business Overview
Table 110. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Baxter Product
Table 112. Baxter Recent Development
Table 113. JN International Medical Corporation Corporation Information
Table 114. JN International Medical Corporation Description and Business Overview
Table 115. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. JN International Medical Corporation Product
Table 117. JN International Medical Corporation Recent Development
Table 118. Serum Institute of India Corporation Information
Table 119. Serum Institute of India Description and Business Overview
Table 120. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Serum Institute of India Product
Table 122. Serum Institute of India Recent Development
Table 123. Bio-Med Corporation Information
Table 124. Bio-Med Description and Business Overview
Table 125. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Bio-Med Product
Table 127. Bio-Med Recent Development
Table 128. China National Biotec Group Corporation Information
Table 129. China National Biotec Group Description and Business Overview
Table 130. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. China National Biotec Group Product
Table 132. China National Biotec Group Recent Development
Table 133. Hualan Bio Corporation Information
Table 134. Hualan Bio Description and Business Overview
Table 135. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Hualan Bio Product
Table 137. Hualan Bio Recent Development
Table 138. Walvax Corporation Information
Table 139. Walvax Description and Business Overview
Table 140. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 141. Walvax Product
Table 142. Walvax Recent Development
Table 143. Zhifei Corporation Information
Table 144. Zhifei Description and Business Overview
Table 145. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 146. Zhifei Product
Table 147. Zhifei Recent Development
Table 148. Meningococcal Vaccine Market Trends
Table 149. Meningococcal Vaccine Market Drivers
Table 150. Meningococcal Vaccine Market Challenges
Table 151. Meningococcal Vaccine Market Restraints
Table 152. Meningococcal Vaccine Customers List
Table 153. Meningococcal Vaccine Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccine Product Picture
Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Meningtits A Product Picture
Figure 4. Polysaccharide Meningtitis AC Product Picture
Figure 5. Meningitis ACYW Product Picture
Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. 6 Months-15Year
Figure 8. over 3 Year
Figure 9. over 2 Year
Figure 10. over 3 Months
Figure 11. Meningococcal Vaccine Report Years Considered
Figure 12. Global Meningococcal Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Meningococcal Vaccine Market Size 2016-2027 (US$ Million)
Figure 14. Global Meningococcal Vaccine Sales 2016-2027 (10K Pcs)
Figure 15. Global Meningococcal Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Meningococcal Vaccine Sales Market Share by Region in 2020
Figure 18. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Meningococcal Vaccine Revenue Market Share by Region in 2020
Figure 20. Global Meningococcal Vaccine Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Meningococcal Vaccine Revenue in 2020
Figure 22. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Figure 24. Global Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 25. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure 26. Global Meningococcal Vaccine Revenue Market Share by Type in 2020
Figure 27. Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Figure 28. Global Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 29. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
Figure 30. Global Meningococcal Vaccine Revenue Market Share by Application in 2020
Figure 31. China Meningococcal Vaccine Sales Growth Rate 2016-2027 (10K Pcs)
Figure 32. China Meningococcal Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Meningococcal Vaccine Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue in Meningococcal Vaccine in 2020
Figure 35. China Meningococcal Vaccine Revenue Share by Type (2016-2021)
Figure 36. China Meningococcal Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Meningococcal Vaccine Revenue Share by Application (2016-2021)
Figure 38. China Meningococcal Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Meningococcal Vaccine Sales Growth Rate 2016-2021 (10K Pcs)
Figure 40. North America Meningococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 42. North America Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 43. U.S. Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 44. U.S. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 46. Canada Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Meningococcal Vaccine Sales Growth Rate 2016-2021 (10K Pcs)
Figure 48. Europe Meningococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 50. Europe Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 51. Germany Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 52. Germany Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 54. France Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 56. U.K. Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 58. Italy Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 60. Russia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Meningococcal Vaccine Sales Growth Rate 2016-2021 (10K Pcs)
Figure 62. Asia Pacific Meningococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2020
Figure 64. Asia Pacific Meningococcal Vaccine Revenue Market Share by Region in 2020
Figure 65. China Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 66. China Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 68. Japan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 70. South Korea Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 72. India Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 74. Australia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 76. China Taiwan Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 78. Indonesia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 80. Thailand Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 82. Malaysia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Meningococcal Vaccine Sales Growth Rate 2016-2021 (10K Pcs)
Figure 84. Latin America Meningococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 86. Latin America Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 87. Mexico Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 88. Mexico Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 90. Brazil Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 92. Argentina Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Meningococcal Vaccine Sales Growth Rate 2016-2021 (10K Pcs)
Figure 94. Middle East and Africa Meningococcal Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Meningococcal Vaccine Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Country in 2020
Figure 97. Turkey Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 98. Turkey Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Saudi Arabia Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 100. Saudi Arabia Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. UAE Meningococcal Vaccine Sales Growth Rate (2016-2021) (10K Pcs)
Figure 102. UAE Meningococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Meningococcal Vaccine Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Bottom-up and Top-down Approaches for This Report
Figure 107. Data Triangulation
Figure 108. Key Executives Interviewed
髄膜炎菌感染症ワクチンの世界市場 2020年 Market Overview The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococca…- 髄膜炎菌ワクチンの世界市場 2020年 Market Overview The Meningococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 23価肺炎球菌多糖ワクチンの世界市場 2020年 Market Overview The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- 結合型ワクチンの世界市場 2020年 Market Overview The global Conjugate Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 10930 million by 2025, from USD 9687.6 million in 2019. The Conjugate Vaccine m…
- 鼻インフルエンザワクチンの世界市場 2020年 Market Overview The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…